Kiromic BioPharma, Inc.
KRBP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $23 | $29 | $89 | $524 |
| - Cash | $1 | $3 | $1 | $25 |
| + Debt | $15 | $16 | $9 | $0 |
| Enterprise Value | $37 | $41 | $97 | $499 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$3 | -$2 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$24 | -$16 | -$32 | -$25 |
| % Margin | – | – | – | – |
| Net Income | -$27 | -$21 | -$38 | -$26 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.03 | -21.41 | -70.12 | -67.4 |
| % Growth | 95.2% | 69.5% | -4% | – |
| Operating Cash Flow | -$19 | -$21 | -$24 | -$20 |
| Capital Expenditures | -$0 | -$0 | -$5 | -$2 |
| Free Cash Flow | -$20 | -$21 | -$29 | -$22 |